Phenyl-indole compounds for modulating IgE and Inhibiting...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S465000, C548S469000, C548S490000, C548S491000, C546S268100, C546S277400, C514S336000, C514S415000

Reexamination Certificate

active

10661139

ABSTRACT:
The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to phenyl-indole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. This invention further relates to small molecules which suppress cytokines and leukocytes.

REFERENCES:
patent: 4510158 (1985-04-01), Bailey
patent: 4582837 (1986-04-01), Hauel et al.
patent: 4696931 (1987-09-01), Hauel et al.
patent: 5017467 (1991-05-01), Masukawa et al.
patent: 5124336 (1992-06-01), Bru-Magniez et al.
patent: 5322847 (1994-06-01), Marfat et al.
patent: 5380865 (1995-01-01), Cramp et al.
patent: 5643893 (1997-07-01), Benson et al.
patent: 5712392 (1998-01-01), Thurkauf et al.
patent: 5821258 (1998-10-01), Matsunanaga et al.
patent: 5935983 (1999-08-01), Muller-Gliemann et al.
patent: 6093728 (2000-07-01), McMahon et al.
patent: 6100282 (2000-08-01), Alig et al.
patent: 6100283 (2000-08-01), Griffin et al.
patent: 6153631 (2000-11-01), Petrie et al.
patent: 6271249 (2001-08-01), Romine et al.
patent: 6271390 (2001-08-01), Sircar et al.
patent: 6288101 (2001-09-01), Glennon
patent: 6303645 (2001-10-01), Sircar et al.
patent: 6369091 (2002-04-01), Sircar et al.
patent: 6387938 (2002-05-01), Mizuguchi et al.
patent: 6451829 (2002-09-01), Sircar et al.
patent: 6486153 (2002-11-01), Castro Pineiro et al.
patent: 6503938 (2003-01-01), Von Angerer et al.
patent: 6509365 (2003-01-01), Lubisch et al.
patent: 6537994 (2003-03-01), Ashwell et al.
patent: 6759425 (2004-07-01), Sircar et al.
patent: 6911462 (2005-06-01), Sircar et al.
patent: 6919366 (2005-07-01), Sircar et al.
patent: 2002/0010343 (2002-01-01), Sircar et al.
patent: 2002/0132808 (2002-09-01), Sircar et al.
patent: 2003/0004203 (2003-01-01), Sircar et al.
patent: 2003/0100582 (2003-05-01), Sircar et al.
patent: 2004/0116466 (2004-06-01), Sircar et al.
patent: 2004/0214821 (2004-10-01), Sircar et al.
patent: 2004/0229927 (2004-11-01), Sircar et al.
patent: 2005/0075343 (2005-04-01), Sircar et al.
patent: 2005/0197375 (2005-09-01), Sircar et al.
patent: 2005/0256179 (2005-11-01), Sircar et al.
patent: 2005/0277686 (2005-12-01), Sircar et al.
patent: 0 221 146 (1987-05-01), None
patent: 0 221 346 (1987-05-01), None
patent: 0 232 199 (1987-08-01), None
patent: 0 353 606 (1990-02-01), None
patent: 0 415 886 (1990-08-01), None
patent: 0 385 850 (1990-09-01), None
patent: 0 469 477 (1992-02-01), None
patent: 0 497 564 (1992-08-01), None
patent: 0 694 535 (1996-01-01), None
patent: 0 700 906 (1996-03-01), None
patent: 0 719 765 (1996-07-01), None
patent: 1 077 700 (2001-02-01), None
patent: 1 123 295 (2001-08-01), None
patent: 1 125 936 (2001-08-01), None
patent: 06 263993 (1994-09-01), None
patent: 1316559 (1983-06-01), None
patent: WO 89 06975 (1989-08-01), None
patent: WO 90 09989 (1990-09-01), None
patent: WO 92/02500 (1992-02-01), None
patent: WO 93 25517 (1993-12-01), None
patent: WO 98 17267 (1998-04-01), None
patent: WO 98 47890 (1998-10-01), None
patent: WO 98 56761 (1998-12-01), None
patent: WO 99 61020 (1999-02-01), None
patent: WO 99 61013 (1999-12-01), None
patent: WO 99 61019 (1999-12-01), None
patent: WO 00 26192 (2000-05-01), None
patent: WO 00 29384 (2000-05-01), None
patent: WO 00 32579 (2000-06-01), None
patent: WO 00 64878 (2000-11-01), None
patent: WO 00 68206 (2000-11-01), None
patent: WO 01 12169 (2001-02-01), None
patent: WO 01 14342 (2001-03-01), None
patent: WO 01 72737 (2001-10-01), None
patent: WO 02 072090 (2002-09-01), None
patent: WO 02 072539 (2002-09-01), None
patent: WO 02 072574 (2002-09-01), None
Related pending U.S. Appl. No. 10/661,296, filed Sep. 12, 2003. Title: Phenyl-Aza-Benzimidazole Compounds for Modulating IgE and Inhibiting Cellular Proliferation. Inventors: Jagadish C. Sircar et al.
Related pending U.S. Appl. No. 10/795,006, filed Mar. 5, 2004. Title: Benzimidazole Compounds for Modulating IgE and Inhibiting Cellular Proliferation. Inventors: Jagadish C. Sircar et al.
Related pending U.S. Appl. No. 10/821,667, filed Apr. 9, 2004. Title: Imidazole Derivatives for Treatment of Allergic and Hyperproliferative Disorders. Inventors: Jagadish C. Sircar et al.
Related pending U.S. Appl. No. 10/915,722, filed Aug. 9, 2004. Title: Selective Pharmacologic Inhibition of Protein Trafficking and Related Methods of Treating Human Diseases. Inventors: Jagadish C. Sircar et al.
Related pending U.S. Appl. No. 10/508,968, filed Sep. 24, 2004. Title: Use of Benzimidazole Analogs in the Treatment of Cell Proliferation. Inventors: Jagadish C. Sircar et al.
Related pending U.S. Appl. No. 10/951,515, filed Sep. 28, 2004. Title: Benzimidazole Derivatives as Modulators of IgE. Inventors: Jagadish C. Sircar et al.
Related pending U.S. Appl. No. 11/168,711, filed Jun. 28, 2005. Title: Benzimidazole Compounds for Regulating IgE. Inventors: Jagadish C. Sircar et al.
Manecke et al., Ü ber Polyamide mit 2,4-Imidazolidiyl-Bausteinen, Die Makromolekulare Chemie 176, pp. 3551-3563, Apr. 29, 1975, Institut für Organische Chemie der Freien Universität Berline, D-1 Berlin 33.
Cheney B V, et al., “Structure-activity Correlations for a Series of Antiallergy Agents. 3. Development of a Quantitative Model,” Journal of Medicinal Chemistry, vol. 26, No. 5, 1983, pp. 726-737.
Pozdnyakov et al., “Mass Spectrometric Study of Dissociative Ionization of Low-molecular Models of Aromatic Polyamides,” Khim. Vys. Energ. (1987), 21(1), 38-44 Coden; Khvkao; ISSN: 0023-1193, 1987.
English language abstract of Pozdnyakov, et al. (1987) “Mass spectrometric study of dissociative ionization of low-molecular models of aromatic polyamides,” vol. 21 (1), pp. 38-44.
Database Crossifre Beilstein ′Online!, Beilstein Institut zur Forderung der Chemischen Wissenchaften, Frankfurt am Main, DE; Beilstein Registry No. 563073 & Khim. Farm. ZH., vol. 22, No. 6, 1988, pp. 697-699.
Karag'ozov S, “Synthesis of N-acyl Derivatives of 6-amio-1-4-benzodioXane,” STN International, vol. 39, No. 1989, pp. 5-8, Abstract only.
Masukawa et al., Calplus 111:31259 (EP 304856, Mar. 1, 1989).
Denny W A et al., “Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboXamides, a new class of “minimal” DNA-intercalating agents which may not act via topoisomerase II”, Journal of Medicinal Chemistry, vol. 33, No. 2, Feb. 1990, pp. 814-819.
Yildir I, “Synthesis of 32-(subtitutephenyl) Benzimidazole Derivatives and their Sedative Activity: Structure-activity Relationships,” Journal FaX. Pharm. Gazi Uni., vol. 7, No. 2, 1990, pp. 111-114.
Timothy F. Gallagher, et al., “2,4,5-Triarylimidazole Inhibitors of IL-1 Biosynthesis,” Bioorganic & Medicinal Chemistry Letters, vol. 5, No. 11, pp. 1171-1176, 1995.
Ashton et al., “New Low-Density Lipoprotein Receptor Upregulators Acting via a Novel Mechanism,” Journal of Medicinal Chemistry, vol. 39, Jan. 1, 1996, pp. 3343-3356.
Krieg et al., ber einige neue Imizazolderivative, Chem. Ber. 100, pp. 4042-4049 (1967), Jun. 28, 1997, Jahrg. 100, Aus dem Institut für Organische Chemie der Freien Universität Berlin, Berlinn-Dahlem.
Kreimeyer A et al., “Suramin analogues with a 2-phenylbenzimidazole moiety as partyial structure; potential anti HIV-and angiostic drugs, 2: Sulfanilic acid, benzendisulfonic, and naphthalenetrisulfonic acid analogues” Archi Der Pharmazie, vol. 331, No. 3, Mar. 1998, pp. 97-103.
Japanese Application No. 10273013, entitled Antagonist for Gonadotrophic Hormone-Releasing Hormone, filed on Sep. 28, 1998, English abstract only.
Database Caplus ′Online! Chemical Abstracts Service, Columbus, Ohio, US; Databse accession No. 2000:214835 & JP 2000 095767 (Takeda Chemical Industries, Ltd.), Apr. 4, 2000.
White A W et al., “Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenyl-indole compounds for modulating IgE and Inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenyl-indole compounds for modulating IgE and Inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl-indole compounds for modulating IgE and Inhibiting... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3915572

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.